The Role of mprF Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Role of
mprF
Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 66, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2021-10-19
DOI
10.1128/aac.01295-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey
- (2021) Yan Chen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Prolonged exposure to β-lactam antibiotics reestablishes susceptibility of daptomycin-nonsusceptible Staphylococcus aureus to daptomycin
- (2020) Rachel E. Jenson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights
- (2020) Razieh Kebriaei et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination Therapy for Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia: Beauty Remains in the Eye of the Beholder
- (2020) Adolf W Karchmer CLINICAL INFECTIOUS DISEASES
- Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA)
- (2020) Kanate Thitiananpakorn et al. Scientific Reports
- Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report
- (2019) François-Régis Duss et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus
- (2019) Ewan M. Harrison et al. Nature Microbiology
- Daptomycin plus beta-lactam combination therapy for methicillin-resistant Staphylococcus aureus bloodstream infections: a retrospective, comparative cohort study
- (2019) Sarah C J Jorgensen et al. CLINICAL INFECTIOUS DISEASES
- In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Strains From Three Endocarditis Patients
- (2019) Shujuan Ji et al. JOURNAL OF INFECTIOUS DISEASES
- The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
- (2018) Cristina García-de-la-Mària et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
- (2018) Sahreena Lakhundi et al. CLINICAL MICROBIOLOGY REVIEWS
- Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance
- (2018) Christoph M. Ernst et al. mBio
- Daptomycin–β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis
- (2016) Henry F. Chambers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus
- (2016) Adriana Renzoni et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
- (2016) William R. Miller et al. Cold Spring Harbor Perspectives in Medicine
- Heterogeneity of Genetic Pathways toward Daptomycin Nonsusceptibility in Staphylococcus aureus Determined by Adjunctive Antibiotics
- (2015) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency and Distribution of Single-Nucleotide Polymorphisms withinmprFin Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides
- (2015) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
- (2015) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial
- (2015) Joshua S. Davis et al. CLINICAL INFECTIOUS DISEASES
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- Persistent Staphylococcus aureus Isolates from Two Independent Cases of Bacteremia Display Increased Bacterial Fitness and Novel Immune Evasion Phenotypes
- (2015) R. L. Richards et al. INFECTION AND IMMUNITY
- Heterogeneity ofmprFSequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides
- (2014) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Basis of Virulence in a Panton-Valentine Leukocidin-Negative Community-Associated Methicillin-ResistantStaphylococcus aureusStrain
- (2014) Yan Chen et al. JOURNAL OF INFECTIOUS DISEASES
- Whole Genome Analysis of a Community-Associated Methicillin-Resistant Staphylococcus aureus ST59 Isolate from a Case of Human Sepsis and Severe Pneumonia in China
- (2014) Tingting Qu et al. PLoS One
- Causal Role of Single Nucleotide Polymorphisms within themprFGene of Staphylococcus aureus in Daptomycin Resistance
- (2013) Soo-Jin Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Current Perspective on Daptomycin for the Clinical Microbiologist
- (2013) R. M. Humphries et al. CLINICAL MICROBIOLOGY REVIEWS
- Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
- (2012) Brian J. Werth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment
- (2012) Pamela A. Moise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms
- (2010) S.-J. Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
- (2010) M. Z. David et al. CLINICAL MICROBIOLOGY REVIEWS
- Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies
- (2009) J. N. Steenbergen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More